Y-Mabs Therapeutics Overview

Y-Mabs Therapeutics Other Income Expense Net

Other Income/Expense Net for YMAB.

Quarterly Other Income/Expense

$2.37M

↑ 270.63% YoY

As of Jun 30, 2025

Annual Other Income/Expense (TTM)

$4.03M

↑ 9.8% YoY

Trailing 12 months ending Jun 30, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin